2209.1An eligible person shall be any of the individuals described in subsection 2209.3 who apply to enroll under the policy not later than sixty-three (63) days after the date of the termination of enrollment described in subsection 2209.3, and who submit evidence of the date of termination, disenrollment or Medicare Part D enrollment with the application for a Medicare supplement policy.
2209.2With respect to eligible persons, an issuer shall not deny or condition the issuance or effectiveness of a Medicare supplement policy described in subsection 2209.4 that is offered and is available for issuance to new enrollees by the issuer, shall not discriminate in the pricing of such a Medicare supplement policy because of health status, claims experience, receipt of health care, or medical condition, and shall not impose an exclusion of benefits based on a preexisting condition under such a Medicare supplement policy.
2209.3An eligible person is an individual described in any of the following:
(a) The individual is enrolled under an employee welfare benefit plan providing health benefits which supplement the benefits under Medicare, and the plan terminates, or the plan ceases to provide all such supplemental health benefits to the individual;(b) The individual is enrolled with a Medicare Advantage organization under a Medicare Advantage plan under Part C of Medicare, and any of the following circumstances apply, or the individual is 65 years of age or older and is enrolled with a Program of All-Inclusive Care for the Elderly (PACE) provider under Section 1894 of the Social Security Act, and there are circumstances similar to those described below that would permit discontinuance of the individual's enrollment with such provider if such individual were enrolled in a Medicare Advantage plan: (1) The organization's or plan's certification has been terminated or otherwise discontinued providing the plan in the area in which the individual resides;(2) The individual is no longer eligible to elect the plan because of a change in the individual's place of residence or other change in circumstances specified by the Secretary, but not including termination of the individual's enrollment on the basis described in section 1851(g) (3) (B) of the Social Security Act (where the individual has not paid premiums on a timely basis or has engaged in disruptive behavior as specified in standards under section 1856), or the plan is terminated for all individuals within a residence area;(3) The individual demonstrates, in accordance with guidelines established by the Secretary, that: (A) The organization offering the plan substantially violated a material provision of the organization's contract under, this part in relation to the individual, including the failure to provide an enrollee on a timely basis medically necessary care for which benefits are available under the plan or the failure to provide such covered care in accordance with applicable quality standards; or(B) The organization, or agent or other entity acting on the organization's behalf, materially misrepresented the plan's provisions in marketing the plan to the individual; or(4) The individual meets such other exceptional conditions as the Secretary may provide;(c) The individual is: (1) Enrolled with one of the following: (A) An eligible organization under a contract under section 1876 of the Social Security Act (Medicare cost);(B) A similar organization operating under demonstration project authority, effective for periods beginning prior to April 1, 1999;(C) An organization under an agreement under section 1833(a) (1) (A) of the Social Security Act (Health care prepayment plan); or(D) An organization under a Medicare Select policy; and(2) The enrollment ceases under the same circumstances that would permit discontinuance of an individual's election of coverage under subsection 2209.3(b) of this chapter;(d) The individual is enrolled under a Medicare supplement policy and the enrollment ceases because: (1) Of the insolvency of the issuer or bankruptcy of the nonissuer organization, or of other involuntary termination of coverage of enrollment under the policy;(2) The issuer of the policy substantially violated a material provision of the policy; or(3) The issuer, or an agent or other entity acting on the issuer's behalf, materially misrepresented the policy's provisions in marketing the policy to the individual;(e) The individual: (1) Was enrolled under a Medicare supplement policy and terminates enrollment and subsequently enrolls for the first time with any Medicare Advantage organization under a Medicare Advantage plan under Part C of Medicare, any eligible organization under a contract under section 1876 (Medicare cost), any similar organization operating under demonstration project authority, an organization under an agreement under section 1833(a) (1) (A) of the Social Security Act (health care prepayment plan), or a Medicare Select policy; and(2) The subsequent enrollment under subparagraph (1) of this paragraph is terminated by the enrollee during any period within the first twelve (12) months of such subsequent enrollment (during which the enrollee is permitted to terminate such subsequent enrollment under section 1851(e) of the Social Security Act);(f) The individual, upon first becoming eligible for benefits under Part A of Medicare at age 65, enrolls in a Medicare Advantage plan under Part C of Medicare, and disenrolls from the plan by not later than twelve (12) months after the effective date of enrollment;or(g) The individual enrolls in a Medicare Part D plan during the initial enrollment period and, at the time of enrollment in Part D, was enrolled under a Medicare supplement policy that covers outpatient prescription drugs and the individual terminates enrollment in the Medicare supplement policy and submits evidence of enrollment in Medicare Part D along with the application for a policy described in subsection 2209.4(d).2209.4The Medicare supplement policy to which an eligible person is entitled under:
(a) Subsections 2209.3(a), (b), (c), and (d) is a Medicare supplement policy which has a benefit package classified as Plan A, B, C, F (including F with a high deductible), K or L offered by any issuer;(b)(1) Subject to subparagraph (2), subsection 2209.3(e) is the same Medicare supplement policy in which the individual was most recently previously enrolled, if available from the same issuer, or, if not so available, a policy described in paragraph (a) of this subsection;(2) After December 31, 2005, if the individual was most recently enrolled in a Medicare supplement policy with an outpatient prescription drug benefit, a Medicare supplement policy described in this subparagraph is:(A) The policy available from the same issuer but modified to remove outpatient prescription drug coverage; or(B) At the election of the policyholder, an A, B, C, F (including F with a high deductible), K or L policy that if offered by any issuer;(c) Subsection 2209.3(f) shall include any Medicare supplement policy offered by any issuer; and(d) Subsection 2209.3(g) is a Medicare supplement policy that has a benefit package classified as Plan A, B, C, F (including F with a high deductible), K or L, and is offered and is available for issuance to new enrollees by the same issuer that issued the individual's Medicare supplement policy with outpatient prescription drug coverage.2209.5Notification shall be provided as follows:
(a) At the time of an event described in subsection 2209.3 because of which an individual loses coverage or benefits due to the termination of a contract or agreement, policy, or plan, the organization that terminates the contract or agreement, the issuer terminating the policy, or the administrator of the plan being terminated, respectively, shall notify the individual of his or her rights under this section, and of the obligations of issuers of Medicare supplement policies under subsection 2209.2. Such notice shall be communicated contemporaneously with the notification of termination.(b) At the time of an event described in subsection 2209.3 because of which an individual ceases enrollment under a contract or agreement, policy, or plan, the organization that offers the contract or agreement, regardless of the basis for the cessation of enrollment, the issuer offering the policy, or the administrator of the plan, respectively, shall notify the individual of his or her rights under this section, and of the obligations of issuers of Medicare supplement policies under subsection 2209.2. Such notice shall be communicated within ten (10) working days of the issuer receiving notification of disenrollment.2209.6Guaranteed issue time periods shall be as follows:
(a) In the case of an individual described in subsection 2209.3(b), the guaranteed issue period begins on the later of: (i) the date the individual receives a notice of termination or cessation of all supplemental health benefits (or, if a notice is not received, notice that a claim has been denied because of such a termination or cessation) or (ii) the date that the applicable coverage terminates or ceases; and ends sixty-three (63) days thereafter;(b) In the case of an individual described in subsection 2209.3(b), 2209.3(c)2209.3(e) or 2209.3(f) whose enrollment is terminated involuntarily, the guaranteed issue period begins on the date that the individual receives a notice of termination and ends sixty-three (63) days after the date the applicable coverage is terminated;(c) In the case of an individual described in subsection 2209.3(d), the guaranteed issue period begins on the earlier of: (i) the date that the individual receives a notice of termination, a notice of the issuers's bankruptcy or insolvency, or other such similar notice if any, and (ii) the date that the applicable coverage is terminated, and ends on the date that is sixty-three (63) days after the date the coverage is terminated;(d) In the case of an individual described in subsections 2209.3(b), 2209.3(d)(2), 2209.3(d)(3), 2209.3(e), or 2209.3(f) who disenrolls voluntarily, the guaranteed issue period begins on the date that is sixty (60) days before the effective date of the disenrollment and ends on the date that is sixty-three (63) days after the effective date; and(e) In the case of an individual described in subsection 2209.3 but not described in the preceding provisions of this subsection, the guaranteed issue period begins on the effective date of disenrollment and ends on the date that is sixty-three (63) days after the effective date.2209.7Extended Medigap access for interrupted trial periods shall be as follows:
(a) In the case of an individual described in subsection 2209.3(e) (or deemed to be so described, pursuant to this paragraph) whose enrollment with an organization or provider described in subsection 2209(e)(1) is involuntarily terminated within the first twelve (12) months of enrollment, and who, without an intervening enrollment, enrolls with another such organization or provider, the subsequent enrollment shall be deemed to be an initial enrollment described in section 2209.3(e);(b) In the case of an individual described in subsection 2209.3(f) (or deemed to be so described, pursuant to this paragraph) whose enrollment with a plan or in a program described in subsection 2209.3(f) is involuntarily terminated within the first twelve (12) months of enrollment, and who, without an intervening enrollment, enrolls in another such plan or program, the subsequent enrollment shall be deemed to be an initial enrollment described in subsection 2209.3(f); and(c) For purposes of subsections 2209.3(e) and 2209.3(f), no enrollment of an individual with an organization or provider described in subsection 2209.3(e)(1), or with a plan or in a program described in subsection 2209.3(f), may be deemed to be an initial enrollment under this paragraph after the two-year period beginning on the date on which the individual first enrolled with such an organization, provider, plan or program.D.C. Mun. Regs. tit. 26, r. 26-A2209
Final Rulemaking published at 46 DCR 10175 (December 17, 1999); as amended by Final Rulemaking published at 50 DCR 4166 (May 30, 2003); as amended by Final Rulemaking published at 50 DCR 5882 (July 25, 2003); as amended by Final Rulemaking published at 53 DCR 2955(April 14, 2006); as amended by Final Rulemaking published at 53 DCR 8467(October 20, 2006)